Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?
Frank G SchaapPeter L M JansenSteven W M Olde DaminkPublished in: Hepatology (Baltimore, Md.) (2017)